Showing results (271-280 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|November 24, 2011
The continuing role of Haemophilus influenzae type b carriage surveillance as a mechanism for early detection of invasive disease activitySusan P JacupsHuman Vaccines|May 25, 2011
Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in SwitzerlandThomas D Szucs, Reto W Kressig, Manto Papageorgiou, et al.Human Vaccines|March 2, 2011
Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plantsQiang Chen, Junyun He, Waranyoo Phoolcharoen, et al.Human Vaccines|March 2, 2011
Emerging antibody products and Nicotiana manufacturingKevin J Whaley, Andrew Hiatt, Larry ZeitlinHuman Vaccines|August 18, 2011
Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patientsSéverine Beaudreuil, Anne Krivine, Hadia Hebibi, et al.Human Vaccines|September 24, 2011
Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, BrazilJoao Tonolio Neto, Gabriela Tannus Branco de Araujo, Anna Gagliardi, et al.Human Vaccines|September 24, 2011
Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adultsFrancisco Hernández-Bernal, Arístides Aguilar-Betancourt, Virginia Aljovin, et al.Human Vaccines|September 24, 2011
Perceptions of malaria and vaccines in KenyaDavid Ojakaa, Emmanuel Yamo, Yvette Collymore, et al.Human Vaccines|September 24, 2011
Active immunotherapeutics forum-Advance phase III active immunotherapy programs: just how well did the pre-clinical and early clinical trials translate? Case studies: with the benefit of hindsight, what are the three biggest lessons learned from pre-clinical and early clinical trials? Meeting report from Barcelona, May 12 2011Will ColónPageof 64